An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies

An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies

Human cytomegalovirus (CMV) is a highly prevalent pathogen with ~60%−90% seropositivity in adults. CMV can contribute to organ rejection in transplant recipients and is a major cause of birth defects in newborns. Currently, there are no approved vaccines against CMV. The epitope of a CMV n...

Full description

Bibliographic Details
Main Authors: Mohammad Amin Behzadi, Kathryn R. Stein, Maria Carolina Bermúdez-González, Viviana Simon, Raffael Nachbagauer, Domenico Tortorella
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Vaccines
Subjects:
influenza virus
human cytomegalovirus
vaccine
humoral immunity
neutralization
hemagglutinin
gH envelope protein
Online Access:https://www.mdpi.com/2076-393X/7/2/51

Internet

https://www.mdpi.com/2076-393X/7/2/51

Similar Items